Ikarian Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-60,000
| Closed | -$1.13M | – | 82 |
|
|
2023
Q1 | $1.13M | Sell |
60,000
-265,000
| -82% | -$4.99M | 0.26% | 49 |
|
|
2022
Q4 | $5.17M | Hold |
325,000
| – | – | 1.25% | 18 |
|
|
2022
Q3 | $5.32M | Buy |
+325,000
| New | +$5.32M | 1.06% | 15 |
|
|
2022
Q2 | – | Sell |
-1,882
| Closed | -$46K | – | 98 |
|
|
2022
Q1 | $46K | Buy |
1,882
+117
| +7% | +$2.86K | 0.01% | 144 |
|
|
2021
Q4 | $42K | Sell |
1,765
-280,000
| -99% | -$6.66M | 0.01% | 140 |
|
|
2021
Q3 | $4.68M | Buy |
281,765
+71,899
| +34% | +$1.19M | 0.33% | 26 |
|
|
2021
Q2 | $5.12M | Buy |
209,866
+203,858
| +3,393% | +$4.97M | 0.41% | 32 |
|
|
2021
Q1 | $155K | Sell |
6,008
-50,000
| -89% | -$1.29M | 0.01% | 164 |
|
|
2020
Q4 | $3M | Hold |
56,008
| – | – | 0.13% | 59 |
|
|
2020
Q3 | $2.31M | Buy |
56,008
+10,000
| +22% | +$412K | 0.17% | 55 |
|
|
2020
Q2 | $2.23M | Buy |
+46,008
| New | +$2.23M | 0.18% | 43 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 75 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 54 |
|